Study of bupivacaine liposome for hip capsular nerve block in elderly patients after hip replacement

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072766

Enrollment

Unknown

Registered

2023-06-25

Start date

2023-07-01

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric orthopedic anesthesia

Interventions

Experimental group:Bupivacaine liposome group

Control group:Non-liposome bupivacaine group

Eligibility

Sex/Gender

All

Age

60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 60 ~ 80 years; 2. ASA I~III grade hip fracture patients; 3. Patients are willing to participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications to regional anesthesia; 2.Patients who are allergic to various anesthetic drugs; 3.Patients with clotting time and platelet count abnormal; 4.Patients with cognitive dysfunction before surgery; 5.The puncture area is infected.

Design outcomes

Primary

Measure	Time frame
Pain score;Postoperative opioid dosage;	—

Secondary

Measure	Time frame
Lower limb movement;	—

Countries

China

Contacts

Public ContactNan Yang

Yuying Children's Hospital, the Second Affiliated Hospital of Wenzhou Medical University

nay0000@163.com+86 139 5774 3658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026